Search results
Edward L. Kuntz Sells 2,500 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) Stock
ETF DAILY NEWS· 4 days agoU.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Edward L. Kuntz sold 2,500 shares of U.S. Physical Therapy stock in a transaction that ...
Pulmatrix (NASDAQ:PULM) Share Price Crosses Above 50 Day Moving Average of $1.87
ETF DAILY NEWS· 4 days agoPulmatrix, Inc. (NASDAQ:PULM – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.87 and traded as high as $1.98 ...
Genetic test may tell who will benefit most from injected weight-loss medications
UPI· 12 hours agoResearch shows that a new test that assigns a genetic risk score to patients may be able to spot who...
TScan Therapeutics (NASDAQ:TCRX) Earns Buy Rating from Analysts at BTIG Research
ETF DAILY NEWS· 3 days agoBTIG Research assumed coverage on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports ...
Brokers Offer Predictions for Unicycive Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:UNCY)
ETF DAILY NEWS· 3 days agoUnicycive Therapeutics, Inc. (NASDAQ:UNCY – Free Report) – Equities researchers at HC Wainwright dropped their Q2 2024 earnings per share (EPS) estimates for shares of Unicycive Therapeutics ...
BioMarin Pharmaceutical (NASDAQ:BMRN) Lowered to Hold at Baird R W
ETF DAILY NEWS· 4 days agoCitigroup cut their price objective on BioMarin Pharmaceutical from $94.00 to $91.00 and set a “neutral” rating for the company in a research note on Thursday, April 25th.
Chardan Capital Weighs in on Ocugen, Inc.’s FY2024 Earnings (NASDAQ:OCGN)
ETF DAILY NEWS· 2 days agoOcugen, Inc. (NASDAQ:OCGN – Free Report) – Chardan Capital boosted their FY2024 earnings per share (EPS) estimates for Ocugen in a research note issued on Wednesday, May 15th ...
Needham & Company LLC Reaffirms Buy Rating for Autolus Therapeutics (NASDAQ:AUTL)
ETF DAILY NEWS· 2 days agoNeedham & Company LLC reaffirmed their buy rating on shares of Autolus Therapeutics (NASDAQ:AUTL – Free Report) in a research note released on Friday, Benzinga reports. They ...
Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com
ETF DAILY NEWS· 2 days agoInvestment analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued to investors on Saturday.
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoLife Science Equipment Market to be Worth $97.96 Billion by 2031 - Exclusive Report by Meticulous Research® PR Newswire REDDING, Calif., May 20, 2024 REDDING, Calif., May 20, 2024 /PRNewswire/ -- According to a new market research report titled,